Intestinal colonization by a lachnospiraceae bacterium contributes to the development of diabetes in obese mice

Microbes and Environments

Volumn 29, Issue 4, 2014, Pages 427-430

  Kameyama, Keishi ^a   Itoh, Kikuji ^b  

^a AJINOMOTO CO INC   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diabetes; Gnotobiotic mouse; Gut microbiota; Lachnospiraceae; T RFLP

Indexed keywords

BACTERIA (MICROORGANISMS); LACHNOSPIRACEAE; MUS;

BACTERIAL DNA; GLUCOSE BLOOD LEVEL; INSULIN;

ANALYSIS; ANIMAL; BLOOD; CHEMISTRY; CLOSTRIDIALES; COMPLICATION; DIABETES MELLITUS; DNA SEQUENCE; FECES; GASTROINTESTINAL TRACT; GENETICS; GLUCOSE BLOOD LEVEL; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; LIVER; MESENTERY; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; CLOSTRIDIALES; DIABETES MELLITUS; DNA, BACTERIAL; FECES; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; INSULIN; LIVER; MESENTERY; MICE, OBESE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 84919449455     PISSN: 13426311     EISSN: 13474405     Source Type: Journal    
DOI: 10.1264/jsme2.ME14054     Document Type: Article

References (23)

1. Cani, P.D., J. Amar, M.A. Iglesias, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772.
2. Cani, P.D., and N.M. Delzenne. 2012. The gut microbiome as therapeutic target. Pharmacol. Ther. 130:202–212.
3. Cani, P.D., S. Possemiers, T. Van de Wiele, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091–1103.
4. Cho, I., S. Yamanishi, L. Cox, et al. 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621–626.
5. Clemente, J.C., L.K. Ursell, L.W. Parfrey, and R. Knight. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270.
6. Cole, J.R., Q. Wang, J.A. Fish, et al. 2014. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42:D633–642.
7. Cox, L.M., and M.J. Blaser. 2013. Pathways in microbe-induced obesity. Cell Metab. 17:883–894.
8. de Vos, W.M., and M. Nieuwdorp. 2013. Genomics: A gut prediction. Nature 498:48–49.
9. Fei, N., and L. Zhao. 2013. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 7:880–884.
10. Hayashi, H., M. Sakamoto, M. Kitahara, and Y. Benno. 2003. Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol. Immunol. 47:557–570.
11. Itoh, K., and T. Mitsuoka. 1985. Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice. Lab. Anim. 19:111–118.
12. Johnson, A.M., and J.M. Olefsky. 2013. The origins and drivers of insulin resistance. Cell 152:673–684.
13. Karlsson, F.H., V. Tremaroli, I. Nookaew, G. Bergström, C.J. Behre, B. Fagerberg, J. Nielsen, and F. Bäckhed. 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498:99–103.
14. Le Chatelier, E., T. Nielsen, J. Qin, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500:541–546.
15. Liu, W.T., T.L. Marsh, H. Cheng, and L.J. Forney. 1997. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl. Environ. Microbiol. 63:4516–4522.
16. Matthews, D.R., J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419.
17. Mehta, N.N., F.C. McGillicuddy, P.D. Anderson, et al. 2010. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172–181.
18. Panwar, H., H.M. Rashmi, V.K. Batish, and S. Grover. 2013. Probiotics as potential biotherapeutics in the management of type 2 diabetes—prospects and perspectives. Diabetes Metab. Res. Rev. 29:103–112.
19. Qin, J., Y. Li, Z. Cai, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60.
20. Samuel, B.S., and J.I. Gordon. 2006. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc. Natl. Acad. Sci. U.S.A. 103:10011–10016.
21. Sanz, Y., A. Santacruz, and P. Gauffin. 2010. Gut microbiota in obesity and metabolic disorders. Proc. Nutr. Soc. 69:434–441.
22. Shafrir, E., E. Ziv, and L. Mosthaf. 1999. Nutritionally induced insulin resistance and receptor defect leading to beta-cell failure in animal models. Ann. N. Y. Acad. Sci. 892:223–246.
23. Tremaroli, V., and F. Bäckhed. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249.